| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Carlos Singer, Spiridon Papapetropoulo. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia. Parkinsonism & related disorders. vol 12. issue 2. 2006-05-01. PMID:16271495. |
oromandibular dystonia (omd) is a form of focal dystonia that affects masticatory, lower facial, and lingual muscles. |
2006-05-01 |
2023-08-12 |
Not clear |
| Steven E Lo, Axel J Rosengart, Roberta L Novakovic, Un Jung Kang, Darshan N Shah, Mohsin A Khan, Arif Dalvi, Fernando D Goldenberg, R Loch Macdonald, Jeffrey I Fran. Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients. Neurocritical care. vol 3. issue 2. 2006-01-24. PMID:16174883. |
primary cervical and oromandibular dystonia (cd and omd, respectively) are well-recognized movement disorders, often treated with botulinum toxin (btx). |
2006-01-24 |
2023-08-12 |
Not clear |
| Hasmet A Hanagasi, Basar Bilgic, Hakan Gurvit, Murat Emr. Clozapine treatment in oromandibular dystonia. Clinical neuropharmacology. vol 27. issue 2. 2004-09-09. PMID:15252269. |
oromandibular dystonia (omd) is a form of focal dystonias, which can be associated with substantial disability and is frequently refractory to all antidystonic therapies. |
2004-09-09 |
2023-08-12 |
Not clear |
| E K Tan, L L Chan, M C Won. Levodopa-induced oromandibular dystonia in progressive supranuclear palsy. Clinical neurology and neurosurgery. vol 105. issue 2. 2003-06-18. PMID:12691807. |
in this report we describe an unusual case of reversible levodopa-induced oromandibular dystonia (omd) in a psp patient to highlight the importance of recognizing this drug related complication in the management of psp, and discuss the possible underlying pathophysiology. |
2003-06-18 |
2023-08-12 |
Not clear |
| K Yoshida, R Kaji, H Shibasaki, T Iizuk. Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology. International journal of oral and maxillofacial surgery. vol 31. issue 5. 2003-01-21. PMID:12418565. |
oromandibular dystonia (omd) is a focal dystonia manifested by involuntary masticatory and/or lingual muscle contractions. |
2003-01-21 |
2023-08-12 |
Not clear |
| R Laskawi, S Rohrbac. [Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin]. Laryngo- rhino- otologie. vol 80. issue 12. 2002-03-05. PMID:11793266. |
the present study reports on our experience with clinical aspects and therapy of oromandibular dystonia (omd) with botulinum toxin a. omd is a very rare form of focal dystonias. |
2002-03-05 |
2023-08-12 |
Not clear |
| J Erdal, L M Werdelin, S Prytz, A Fuglsang-Frederiksen, E Mølle. [Botulinum toxin treatment of patients with oromandibular dystonia]. Ugeskrift for laeger. vol 162. issue 48. 2001-02-08. PMID:11187229. |
oromandibular dystonia (omd) is a frequently disabling focal dystonia, which may be treated with injections of botulinum toxin in the affected muscles. |
2001-02-08 |
2023-08-12 |
Not clear |
| E K Tan, J Jankovi. Tardive and idiopathic oromandibular dystonia: a clinical comparison. Journal of neurology, neurosurgery, and psychiatry. vol 68. issue 2. 2000-03-01. PMID:10644785. |
to compare clinical features and response to botulinum toxin (btx) injections between patients with tardive and idiopathic oromandibular dystonia (omd). |
2000-03-01 |
2023-08-12 |
Not clear |
| E K Tan, J Jankovi. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology. vol 53. issue 9. 2000-01-04. PMID:10599789. |
to study the safety and efficacy of botulinum toxin a (btx) in patients with oromandibular dystonia (omd) and to compare the treatment results of the various subtypes of omd. |
2000-01-04 |
2023-08-12 |
Not clear |
| C Sankhla, E C Lai, J Jankovi. Peripherally induced oromandibular dystonia. Journal of neurology, neurosurgery, and psychiatry. vol 65. issue 5. 1998-12-10. PMID:9810945. |
oromandibular dystonia (omd) is a focal dystonia manifested by involuntary muscle contractions producing repetitive, patterned mouth, jaw, and tongue movements. |
1998-12-10 |
2023-08-12 |
Not clear |
| C Sankhla, E C Lai, J Jankovi. Peripherally induced oromandibular dystonia. Journal of neurology, neurosurgery, and psychiatry. vol 65. issue 5. 1998-12-10. PMID:9810945. |
peripherally induced cervical and limb dystonia is well recognised, and the aim of this study was to characterise peripherally induced omd. |
1998-12-10 |
2023-08-12 |
Not clear |
| P D Charles, T L Davis, K M Shannon, M A Hook, J S Warne. Tongue protrusion dystonia: treatment with botulinum toxin. Southern medical journal. vol 90. issue 5. 1997-06-12. PMID:9160072. |
we report the treatment experience in a series of patients with involuntary tongue protrusion resulting from oromandibular dystonia (omd) or meige's syndrome. |
1997-06-12 |
2023-08-12 |
Not clear |
| G Defazio, V Lepore, G Abbruzzese, E Barontini, A Berardelli, T Caraceni, F Carella, P Girlanda, M Manfredi, C Messin. Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia: a multicenter study. Movement disorders : official journal of the Movement Disorder Society. vol 9. issue 6. 1995-03-08. PMID:7845401. |
the reliability of a scale of 0 to 4 (where 0 is normal) in rating the severity of blepharospasm (bs) and oromandibular dystonia (omd) was evaluated by the concordance among six neurologists from different neurological institutions. |
1995-03-08 |
2023-08-12 |
Not clear |
| E Sforza, P Montagna, G Defazio, E Lugares. Sleep and cranial dystonia. Electroencephalography and clinical neurophysiology. vol 79. issue 3. 1991-09-26. PMID:1714808. |
a nocturnal polygraphic study was performed on 10 patients with cranial dystonia (blepharospasm (bs) and oromandibular dystonia (omd)). |
1991-09-26 |
2023-08-11 |
human |
| G Defazio, P Lamberti, V Lepore, P Livrea, E Ferrar. Facial dystonia: clinical features, prognosis and pharmacology in 31 patients. Italian journal of neurological sciences. vol 10. issue 6. 1990-03-08. PMID:2515166. |
the natural history and response to different treatments were assessed in 31 consecutive patients with blepharospasm (bs) and/or oromandibular dystonia (omd). |
1990-03-08 |
2023-08-11 |
Not clear |
| G Defazio, P Lamberti, V Lepore, P Livrea, E Ferrar. Facial dystonia: clinical features, prognosis and pharmacology in 31 patients. Italian journal of neurological sciences. vol 10. issue 6. 1990-03-08. PMID:2515166. |
when omd was the first symptom, a lower tendency of dystonia to progress elsewhere was observed. |
1990-03-08 |
2023-08-11 |
Not clear |
| M F Brin, S Fahn, C Moskowitz, A Friedman, H M Shale, P E Greene, A Blitzer, T List, D Lange, R E Lovelac. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Movement disorders : official journal of the Movement Disorder Society. vol 2. issue 4. 1989-01-17. PMID:3504553. |
we have used local injections of botulinum toxin into the appropriate muscles for treatment of disabling focal or segmental dystonia in 93 patients with torticollis, blepharospasm, oromandibular dystonia (omd), limb dystonia, lingual dystonia, and dystonia adductor dysphonia, in addition to four patients with hemifacial spasm. |
1989-01-17 |
2023-08-11 |
Not clear |
| G Ransmayr, B Kleedorfer, R A Dierckx, W Poewe, G W Kemmler, F Gerstenbran. Pharmacological study in Meige's syndrome with predominant blepharospasm. Clinical neuropharmacology. vol 11. issue 1. 1988-04-25. PMID:3280128. |
the symptoms of the patients [idiopathic blepharospasm (ib), in 11 patients, oromandibular dystonia (omd) in four patients] were quantified by a blind observer counting the frequencies and recording the cumulative duration of sustained spasms of ib and omd over periods of 4 min before, and 15, 30, 60, 90, and 120 min after the i.v. |
1988-04-25 |
2023-08-11 |
Not clear |
| D Hípola, D Mateo, S Giménez-Roldá. Meige's syndrome: acute and chronic responses to clonazepan and anticholinergics. European neurology. vol 23. issue 6. 1985-02-21. PMID:6510447. |
both drugs were less effective on the associated oromandibular dystonia (omd) observed in 3 of the cases, relief again being greater when using cnz (87.3%) compared to bh (58.3%). |
1985-02-21 |
2023-08-12 |
Not clear |
| D Hípola, D Mateo, S Giménez-Roldá. Meige's syndrome: acute and chronic responses to clonazepan and anticholinergics. European neurology. vol 23. issue 6. 1985-02-21. PMID:6510447. |
though both blepharospasm and omd are thought to represent focal dystonia at different body sites, the extent of improvement achieved with these drugs at the dosage employed differed markedly. |
1985-02-21 |
2023-08-12 |
Not clear |